A subsidiary of NMS Pharmaceuticals Inc. in Newport Beach will begin marketing its urine blood test, a quick method for screening potential urinary tract problems, to consumers and professionals in late August, the company said last week.
The U.S. Food and Drug Administration has approved the marketing of the dip-stick test produced by NMS's Self Care Systems Inc. subsidiary, the parent company said. The product is the most sensitive one available for diagnosing blood in the urine, NMS said.
The consumer product, which is currently in production, will consist of six sticks that, when dipped in urine, change colors to indicate traces of blood. Blood in urine can be an indication of infection, kidney stones, cancer or other urinary tract disorders.